Ravikiran Yerabolu
Moderna, Inc.
Dr. Ravikiran Yerabolu began his career at Moderna in 2018, as a mass spectrometry scientist and was responsible for developing analytical methods for the characterization of mRNA, lipids and drug product for the group. Currently, he assumes the role of a senior scientist, leading a team to characterize lipids and drug product. Before joining Moderna, he received his Ph.D. from Purdue university, with a research focus on developing analytical methods for the characterization of complex mixtures such as crude oil, polymers and drug metabolites.